FR2409980A1
(fr)
*
|
1977-11-24 |
1979-06-22 |
Synthelabo |
Ethers de phenols et leur application en therapeutique
|
IT1147311B
(it)
*
|
1980-02-13 |
1986-11-19 |
Stabil Bioterapico Farmachim |
Eteri basici di 4-idrossi-benzofenoni con attivita' quali agenti betabloccanti e relativi procedimento di preparazione
|
ZW9881A1
(en)
*
|
1980-06-02 |
1981-12-23 |
Hoffmann La Roche |
Substituted phenoxyaminopropanol derivatives
|
DE3125870C2
(de)
*
|
1980-07-09 |
1994-09-15 |
William John Louis |
3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
|
CH643527A5
(en)
*
|
1980-10-24 |
1984-06-15 |
Ciba Geigy Ag |
Process for the preparation of 1-alkylamino-3-(4-(2-lower alkoxy-ethyl)phenoxy)-2-propanols
|
US5347050A
(en)
*
|
1980-11-06 |
1994-09-13 |
Richard Berthold |
3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
|
FI76551C
(fi)
|
1980-11-06 |
1988-11-10 |
Sandoz Ag |
Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-aminopropoxifenylderivat.
|
JPS57108047A
(en)
*
|
1980-11-06 |
1982-07-05 |
Sandoz Ag |
3-aminopropoxyphenyl derivative, manufacture and pharmaceutical composition containing same
|
DE3125636A1
(de)
*
|
1981-06-30 |
1983-01-13 |
Merck Patent Gmbh, 6100 Darmstadt |
1-(p-2-isopropoxyethoxymethyl-phenoxy)-3-isopropylamino-propan-2-ol zur senkung des augeninnendrucks und ophtalmikum, enthalten diese verbindung
|
FR2512443A1
(fr)
*
|
1981-09-10 |
1983-03-11 |
Synthelabo |
Derives de phenoxy-3 propanol-2, leur preparation et leur application en therapeutique
|
DE3151201A1
(de)
*
|
1981-12-23 |
1983-07-28 |
Beiersdorf Ag, 2000 Hamburg |
Substituierte phenoxyalkanolamine und phenoxyalkanol-cycloalkylamine, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische zubereitungen und zwischenprodukte
|
US4450172A
(en)
*
|
1982-03-10 |
1984-05-22 |
E. I. Du Pont De Nemours And Company |
Antihypertensive polyhalohydroxyisopropyl phenylalka(e)noic acid esters of alkylaminohydroxypropyloxyphenylalkyl alcohols
|
FR2536390B1
(fr)
*
|
1982-11-22 |
1986-03-21 |
Synthelabo |
Isomere s du betaxolol, sa preparation et son application en therapeutique
|
CA1262729A
(fr)
*
|
1983-10-19 |
1989-11-07 |
Leo Alig |
Phenoxypropanolamines
|
US5166218A
(en)
*
|
1983-10-19 |
1992-11-24 |
Hoffmann-La Roche Inc. |
Phenoxypropanolamines and pharmaceutical compositions thereof
|
NZ211815A
(en)
*
|
1984-05-15 |
1988-11-29 |
Warner Lambert Co |
Preparation of 1-((3,4-dimethoxyphenethyl)amino)-3- (3-tolyloxy)-2-propanol
|
GB8412864D0
(en)
*
|
1984-05-19 |
1984-06-27 |
Smith Kline French Lab |
Chemical compounds
|
US5554367A
(en)
*
|
1984-10-31 |
1996-09-10 |
Alcon Laboratories, Inc. |
Compositions for treatment of glaucoma
|
ES8609190A1
(es)
*
|
1985-02-07 |
1986-07-16 |
Pharma Investi S A |
Un procedimiento para preparar eteres fenolicos
|
US5095151A
(en)
*
|
1985-05-21 |
1992-03-10 |
American Home Products Corporation |
Preparation of propranolol hydrochloride macrocrystals
|
EP0252007A3
(fr)
*
|
1986-06-28 |
1989-07-05 |
Ciba-Geigy Ag |
Dérivés de 2-propanol comme inhibiteurs de corrosion
|
US4694022A
(en)
*
|
1986-12-24 |
1987-09-15 |
Alcon Laboratories, Inc. |
Fatty acid salts of betaxolol useful in the treatment of glaucoma
|
EP0300290B1
(fr)
*
|
1987-07-21 |
1991-12-18 |
F. Hoffmann-La Roche Ag |
Phénoxypropanolamines
|
FR2672594B1
(fr)
*
|
1991-02-08 |
1994-07-01 |
Synthelabo |
Derives d'ethers de phenols, leur preparation et leur application en therapeutique.
|
JP4241926B2
(ja)
*
|
1995-10-10 |
2009-03-18 |
ウィリアム ジョン ルイス |
3―アミノ―プロポキシフェニル誘導体(1)
|
CA2193149C
(fr)
*
|
1995-12-22 |
2002-04-23 |
David H. Donabedian |
Systemes cationiques therapeutiques
|
US5942633A
(en)
*
|
1996-06-19 |
1999-08-24 |
Abbott Laboratories |
Process for the selective alkylation of betaxolol intermediates
|
US5731463A
(en)
*
|
1996-09-23 |
1998-03-24 |
Abbott Laboratories |
Selective alkylation of an alcohol substituted phenol compound
|
ES2347027T3
(es)
|
1998-05-22 |
2010-10-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Moleculas bifuncionales y terapias basadas en las mismas.
|
US6258350B1
(en)
|
1999-01-20 |
2001-07-10 |
Alcon Manufacturing, Ltd. |
Sustained release ophthalmic formulation
|
ATE253905T1
(de)
*
|
1999-11-30 |
2003-11-15 |
Alcon Inc |
Verwendung von beta-rezeptorenblocker zur herstellung eines medikaments zur behandlung von krankheiten der äusseren retina
|
CA2415789A1
(fr)
*
|
2000-07-27 |
2002-02-07 |
Pharmacia Corporation |
Polytherapie par antagoniste d'aldosterone epoxy-steroidien et antagoniste beta-adrenergique pour le traitement de l'insuffisance cardiaque congestive
|
CA2450073C
(fr)
|
2001-07-25 |
2017-08-29 |
Biomarin Pharmaceutical Inc. |
Compositions et procedes de modulation du transport a travers la barriere hematho-encephalique
|
US7001615B1
(en)
|
2001-12-07 |
2006-02-21 |
Alcon, Inc. |
Sustained release ophthalmic, otic and nasal suspension
|
AP2005003232A0
(en)
|
2002-08-19 |
2005-03-31 |
Pfizer Prod Inc |
Combination therapy for hyperproliferative diseases.
|
US7923467B2
(en)
*
|
2003-05-30 |
2011-04-12 |
Ranbaxy Laboratories, Inc. |
Substituted pyrrole derivatives and their use as HMG-CO inhibitors
|
CN1300079C
(zh)
*
|
2004-12-03 |
2007-02-14 |
南京大学 |
合成4-[2-(环丙基甲氧基)乙基]苯酚的新工艺
|
EP2392258B1
(fr)
|
2005-04-28 |
2014-10-08 |
Proteus Digital Health, Inc. |
Systeme pharma-informatique
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
JP2009514851A
(ja)
*
|
2005-11-08 |
2009-04-09 |
ランバクシー ラボラトリーズ リミテッド |
(3r,5r)−7−[2−(4−フルオロフェニル)−5−イソプロピル−3−フェニル−4−[(4−ヒドロキシメチルフェニルアミノ)カルボニル]−ピロール−1−イル]−3,5−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
CL2007000667A1
(es)
*
|
2006-03-14 |
2008-03-14 |
Ranbaxi Lab Ltd |
Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e
|
RU2009105089A
(ru)
*
|
2006-07-14 |
2010-08-27 |
Ранбакси Лабораториз Лимитед (In) |
ПОЛИМОРФНЫЕ ФОРМЫ ГМГ-КоА-РЕДУКТАЗЫ И ИХ ПРИМЕНЕНИЕ
|
WO2008033466A2
(fr)
*
|
2006-09-14 |
2008-03-20 |
Combinatorx (Singapore) Pre. Ltd. |
Compositions et procédés pour le traitement de maladies virales
|
KR20090071598A
(ko)
|
2006-09-18 |
2009-07-01 |
랩터 파마슈티컬 인코포레이티드 |
수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
|
CN101663262B
(zh)
|
2006-12-01 |
2014-03-26 |
百时美施贵宝公司 |
用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
|
CN101622243B
(zh)
|
2007-02-28 |
2013-12-04 |
旭化成制药株式会社 |
磺酰胺衍生物
|
US9782488B2
(en)
|
2007-03-12 |
2017-10-10 |
Nektar Therapeutics |
Oligomer-beta blocker conjugates
|
EP2050441A1
(fr)
*
|
2007-10-19 |
2009-04-22 |
Université Victor Segalen Bordeaux 2 |
Utilisation de bêtabloquants pour la fabrication d'un médicament pour le traitement d'hémangiomes
|
US8987262B2
(en)
|
2007-10-19 |
2015-03-24 |
Universite de Bordeaux |
Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
|
JP2009040769A
(ja)
*
|
2008-07-09 |
2009-02-26 |
William John Louis |
3−アミノ−プロポキシフェニル誘導体(i)
|
EP2398500B1
(fr)
|
2009-02-20 |
2019-03-13 |
2-BBB Medicines B.V. |
Sustème d'administration de médicament à base de glutathionne
|
MY163048A
(en)
|
2009-05-06 |
2017-08-15 |
Laboratory Skin Care Inc |
Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
CA2909442A1
(fr)
|
2013-04-17 |
2014-10-23 |
Pfizer Inc. |
Derives de n-piperidin-3-ylbenzamide dans le traitement des maladies cardiovasculaires
|
WO2016055901A1
(fr)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Composés d'amide substitué
|
CN113574055A
(zh)
|
2019-01-18 |
2021-10-29 |
阿斯利康(瑞典)有限公司 |
Pcsk9抑制剂及其使用方法
|